Long-term multidrug- and rifampicin-resistant tuberculosis treatment outcome by new WHO definitions in Germany
Ralf Otto-Knapp, Brit Häcker, David J. Krieger, Katarina Stete, Katharina Starzacher, Christina Maier, Jan Heyckendorf, Korkut Avsar, et al. (13 authors)
European Respiratory Journal · 2022-11
Abstract
<b>Long-term outcomes of MDR/RR-TB with 3-year follow-up show 62% favourable outcomes in Germany. 26% were lost to follow-up or transferred. It was possible to categorise 95% of favourable outcomes as cured using the 2021 WHO outcome definitions.</b> https://bit.ly/3bJnvfR
MeSH terms
- Medicine
- Rifampicin
- Tuberculosis
- Outcome (game theory)
- Term (time)
- Multiple drug resistance
- Pediatrics
- Internal medicine
- Intensive care medicine